More about

Biomarker

News
February 23, 2023
1 min read
Save

Retinal flavoprotein fluorescence could be new biomarker of AMD stage, progression

Retinal flavoprotein fluorescence could be new biomarker of AMD stage, progression

Mitochondrial flavoprotein fluorescence may possibly serve as an indicator of age-related macular degeneration stage, helping to detect early disease and offering insights on how and when to treat patients, according to a study.

News
February 22, 2023
2 min read
Save

Conventional memory B, T cells potential biomarkers for juvenile dermatomyositis

Conventional memory B, T cells potential biomarkers for juvenile dermatomyositis

Conventional memory B cells with low CXCR5 levels and CXCR5 T-helper 2 memory cells are potential biomarkers of juvenile dermatomyositis disease activity, according to data published in Arthritis & Rheumatology.

News
February 21, 2023
1 min read
Save

Updated AGA guidelines urge use of biomarkers for the management of UC

Updated AGA guidelines urge use of biomarkers for the management of UC

New AGA clinical practice guidelines highlight the role of noninvasive biomarkers, including fecal calprotectin, fecal lactoferrin and C-reactive protein, for the management of patients with ulcerative colitis.

News
February 18, 2023
2 min read
Save

Biomarkers may predict outcomes with enfortumab vedotin for advanced urothelial carcinoma

Biomarkers may predict outcomes with enfortumab vedotin for advanced urothelial carcinoma

SAN FRANCISCO — Several potential genetic biomarkers may predict how patients with advanced urothelial carcinoma will respond to enfortumab vedotin, according to retrospective study results.

News
February 06, 2023
2 min read
Save

Plasma P-tau217 predicts cognitive decline in preclinical Alzheimer’s disease

Plasma P-tau217 predicts cognitive decline in preclinical Alzheimer’s disease

The plasma biomarker P-tau217 predicted cognitive decline in patients with preclinical Alzheimer’s disease and may complement cerebrospinal fluid and positron emission tomography as a patient-screening tool in clinical trials.

News
January 25, 2023
1 min read
Save

New blood test ‘more accurate’ in identifying, predicting osteoarthritis progression

New blood test ‘more accurate’ in identifying, predicting osteoarthritis progression

A new blood test may offer a more accurate way to track and predict the progression of knee osteoarthritis than current approaches, according to a press release from Duke Health.

News
January 13, 2023
1 min read
Save

LinusBio raises $16M for novel platform to aid diagnosis, treatment of ALS, autism

LinusBio raises $16M for novel platform to aid diagnosis, treatment of ALS, autism

LinusBio announced it has raised over $16 million in Series A funding to deliver technology that combines genomics, the environment and biological response to help diagnose and monitor the progression of disorders such as ALS and autism.

News
January 12, 2023
1 min read
Save

Cerveau, Prothena to use novel tau biomarker for research into neurodegenerative disease

Cerveau, Prothena to use novel tau biomarker for research into neurodegenerative disease

Cerveau Technologies Inc. announced a partnership with Othair Prothena Limited, which will allow Prothena to use Cerveau’s investigational imaging agent in positron emission tomography scans to assess neurofibrillary tangles in the brain.

News
January 11, 2023
2 min read
Save

ECG abnormalities, biomarker elevations among signs of cardiac involvement in COVID-19

ECG abnormalities, biomarker elevations among signs of cardiac involvement in COVID-19

In a study of patients with COVID-19 who underwent cardiac MRI, among the signs of cardiac involvement in COVID-19 were cardiac symptoms, ECG abnormalities and cardiac biomarker elevations.

News
January 09, 2023
3 min read
Save

Blood-based biomarkers linked to immune checkpoint inhibitor-induced myocarditis

Blood-based biomarkers linked to immune checkpoint inhibitor-induced myocarditis

Most patients with cancer diagnosed with myocarditis after receiving immune checkpoint inhibitors showed evidence of liver dysfunction and muscle degradation, results of an observational cohort study in JACC CardioOncology showed.

View more